Secondary pulmonary arterial hypertension
ICD-10 I27.21 is a billable code used to indicate a diagnosis of secondary pulmonary arterial hypertension.
Secondary pulmonary arterial hypertension (PAH) is a condition characterized by elevated blood pressure in the pulmonary arteries due to underlying health issues. This form of hypertension is often a consequence of other diseases, such as left heart disease, chronic lung diseases (like COPD), or thromboembolic disorders. Clinically, patients may present with symptoms such as dyspnea on exertion, fatigue, chest pain, and syncope. The anatomy involved includes the right ventricle, which must work harder to pump blood through the narrowed pulmonary arteries, leading to right ventricular hypertrophy and potential heart failure over time. Disease progression can vary, but untreated secondary PAH can lead to significant morbidity and mortality. Diagnostic considerations include echocardiography, right heart catheterization, and imaging studies to assess pulmonary artery pressures and identify underlying causes. Accurate diagnosis is crucial for effective management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I27.21 covers pulmonary arterial hypertension that is secondary to other conditions such as chronic obstructive pulmonary disease (COPD), left heart disease, or pulmonary embolism. It is essential to document the underlying cause to support the use of this code.
I27.21 should be used when the pulmonary arterial hypertension is specifically identified as secondary to another condition. If the hypertension is primary or unspecified, other codes such as I27.20 should be considered.
Documentation should include clinical findings, diagnostic imaging results, and any relevant laboratory tests that indicate the presence of secondary pulmonary arterial hypertension. Clear linkage to the underlying condition is crucial.
